One-year Real-world Outcomes With Faricimab in Neovascular Age-related Macular Degeneration
{{output}}
Background and objective: This study evaluated real-world treatment patterns and 1-year outcomes in patients with neovascular age-related macular degeneration (nAMD) initiating faricimab. ... ...
